Sinha, Sanju http://orcid.org/0000-0002-2688-0603
Vegesna, Rahulsimham
Mukherjee, Sumit http://orcid.org/0000-0001-9807-7994
Kammula, Ashwin V. http://orcid.org/0000-0001-5284-721X
Dhruba, Saugato Rahman http://orcid.org/0000-0001-5947-6757
Wu, Wei http://orcid.org/0000-0002-6556-067X
Kerr, D. Lucas http://orcid.org/0000-0002-0557-8341
Nair, Nishanth Ulhas http://orcid.org/0000-0002-8832-0329
Jones, Matthew G.
Yosef, Nir
Stroganov, Oleg V.
Grishagin, Ivan
Aldape, Kenneth D. http://orcid.org/0000-0001-5119-7550
Blakely, Collin M. http://orcid.org/0000-0001-8134-3651
Jiang, Peng http://orcid.org/0000-0002-7828-5486
Thomas, Craig J. http://orcid.org/0000-0001-9386-9001
Benes, Cyril H. http://orcid.org/0000-0002-8751-9707
Bivona, Trever G. http://orcid.org/0000-0001-5734-4128
Schäffer, Alejandro A. http://orcid.org/0000-0002-2147-8033
Ruppin, Eytan http://orcid.org/0000-0002-7862-3940
Article History
Received: 20 June 2023
Accepted: 8 March 2024
First Online: 18 April 2024
Competing interests
: S.S., R.V., A.A.S. and E.R. are inventors on a provisional patent application covering the methods in PERCEPTION. E.R. is a co-founder of Medaware, Metabomed and Pangea Biomed (divested from the latter). E.R. serves as a non-paid scientific consultant to Pangea Biomed, a company developing a precision oncology SL-based multi-omics approach, with emphasis on bulk tumor transcriptomics. T.G.B. is an advisor to Array/Pfizer, Revolution Medicines, Springworks, Jazz Pharmaceuticals, Relay Therapeutics, Rain Therapeutics and Engine Biosciences, and receives research funding from Novartis, Strategia, Kinnate and Revolution Medicines. The work in the laboratory of C.H.B. was funded in part by Amgen and Novartis. The other authors declare no competing interests.